Drug Approval | September 01, 2022
Biological E. announces CDSCO recommendation of its infant’s vaccine
Subject Expert Committee(SEC) of Central Drugs Standard Control Organization (CDSCO)
Subject Expert Committee(SEC) of Central Drugs Standard Control Organization (CDSCO)
The approval comes soon after Corbevax was given the nod for 12-15-year group
Primarily set up to address the Covid-19 emergency, the WHO technology transfer hub has the potential to expand manufacturing capacity for other products as well, including treatments, and target other priorities such as malaria, HIV and cancer
To date, 30 crore vaccines have been produced as part of the commitment made to the Government of India
It is India’s 1st indigenously developed Receptor Binding Domain Protein sub-unit vaccine against Covid-19
It plans to deliver over 300 million doses to the Indian government
Support from DFC will help produce one billion vaccine doses by the end of 2022
Subscribe To Our Newsletter & Stay Updated
